Cannell & Spears’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.7M Sell
2025
Q1
$4.43M Buy
2024
Q4
$3.15M Buy
2024
Q3
$593K Buy
2024
Q2
$698K Buy
2024
Q1
$544K Buy
2023
Q4
$437K Buy
2023
Q3
$202K Buy
2021
Q4
Sell
2021
Q3
$542K Buy